| Dr Tamerut Anna Adams, DO | |
|
117 E Main St Ste A100, Payson, AZ 85541-4606 | |
| (928) 596-4500 | |
| (928) 596-4545 |
| Full Name | Dr Tamerut Anna Adams |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 23 Years |
| Location | 117 E Main St Ste A100, Payson, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346233921 | NPI | - | NPPES |
| 209174705 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 006740 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hospice Of Payson, Llc | Payson, AZ | Hospice |
| Hospice Compassus-payson | Payson, AZ | Hospice |
| Banner Payson Medical Center | Payson, AZ | Hospital |
| Rim Country Health & Retirement Community | Payson, AZ | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bhsm Rehabilitation Llc | 2062773138 | 1258 |
News Archive
A new study shows that walking reduces risk of functional limitation associated with knee osteoarthritis (OA). In fact, the study funded in part by grants from the National Institutes of Health (NIH) and published in the American College of Rheumatology (ACR) journal, Arthritis Care & Research, suggests that walking 6,000 or more steps per day may protect those with or at risk of knee of OA from developing mobility issues, such as difficulty getting up from a chair and climbing stairs.
Eighty-four percent of children 18 and younger had successful clinical outcomes during an eight year follow-up to repair a torn meniscus (cartilage that provides cushioning to distribute your body weight across the knee joint) at the same time as reconstruction of the anterior cruciate ligament (ACL), according to a new study presented today at the American Orthopaedic Society for Sports Medicine's Specialty Day in New Orleans, (March 13).
Medtronic Inc. today announced the CE mark and international launch of the Endurant II AAA Stent Graft System, which meaningfully expands the options physicians outside the United States have to treat patients with abdominal aortic aneurysms through a minimally invasive technique called endovascular aortic repair.
Novo Nordisk, a global healthcare company, announced today the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza® (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. Victoza is indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
› Verified 8 days ago
| Entity Name | Banner Primary Care Physicians Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417238908 PECOS PAC ID: 6406020155 Enrollment ID: O20111115000898 |
News Archive
A new study shows that walking reduces risk of functional limitation associated with knee osteoarthritis (OA). In fact, the study funded in part by grants from the National Institutes of Health (NIH) and published in the American College of Rheumatology (ACR) journal, Arthritis Care & Research, suggests that walking 6,000 or more steps per day may protect those with or at risk of knee of OA from developing mobility issues, such as difficulty getting up from a chair and climbing stairs.
Eighty-four percent of children 18 and younger had successful clinical outcomes during an eight year follow-up to repair a torn meniscus (cartilage that provides cushioning to distribute your body weight across the knee joint) at the same time as reconstruction of the anterior cruciate ligament (ACL), according to a new study presented today at the American Orthopaedic Society for Sports Medicine's Specialty Day in New Orleans, (March 13).
Medtronic Inc. today announced the CE mark and international launch of the Endurant II AAA Stent Graft System, which meaningfully expands the options physicians outside the United States have to treat patients with abdominal aortic aneurysms through a minimally invasive technique called endovascular aortic repair.
Novo Nordisk, a global healthcare company, announced today the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza® (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. Victoza is indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tamerut Anna Adams, DO 117 E Main St Ste A100, Payson, AZ 85541-4606 Ph: (928) 596-4500 | Dr Tamerut Anna Adams, DO 117 E Main St Ste A100, Payson, AZ 85541-4606 Ph: (928) 596-4500 |
News Archive
A new study shows that walking reduces risk of functional limitation associated with knee osteoarthritis (OA). In fact, the study funded in part by grants from the National Institutes of Health (NIH) and published in the American College of Rheumatology (ACR) journal, Arthritis Care & Research, suggests that walking 6,000 or more steps per day may protect those with or at risk of knee of OA from developing mobility issues, such as difficulty getting up from a chair and climbing stairs.
Eighty-four percent of children 18 and younger had successful clinical outcomes during an eight year follow-up to repair a torn meniscus (cartilage that provides cushioning to distribute your body weight across the knee joint) at the same time as reconstruction of the anterior cruciate ligament (ACL), according to a new study presented today at the American Orthopaedic Society for Sports Medicine's Specialty Day in New Orleans, (March 13).
Medtronic Inc. today announced the CE mark and international launch of the Endurant II AAA Stent Graft System, which meaningfully expands the options physicians outside the United States have to treat patients with abdominal aortic aneurysms through a minimally invasive technique called endovascular aortic repair.
Novo Nordisk, a global healthcare company, announced today the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza® (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. Victoza is indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
› Verified 8 days ago
Dr. Nagendra Gupta, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 807 S Ponderosa St, Payson, AZ 85541 Phone: 928-474-1398 Fax: 928-472-3429 | |
Judith A Hunt, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 806 S Ponderosa St, Payson, AZ 85541 Phone: 928-468-8603 Fax: 928-468-8625 | |
Dr. Robert Rimmer Jr., MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 708 Coeur D Alene, Ste A, Payson, AZ 85541 Phone: 928-472-7440 Fax: 928-472-7536 | |
Jaber Abawi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1106 N Beeline Hwy, Payson, AZ 85541 Phone: 928-474-5286 Fax: 928-474-0008 | |
Claudio G Zamorano, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 708 Coeur D'alene, Suite B, Payson, AZ 85541 Phone: 928-474-2175 Fax: 928-474-9424 | |
Mona Youssef, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 W Cedar Ln Ste A, Payson, AZ 85541 Phone: 623-433-0202 Fax: 623-433-0204 |